Sutton Wealth Advisors Inc. Repligen Corp Transaction History

Sutton Wealth Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$154.26 - $198.1 $925 - $1,188	-6 Reduced 54.55%	5 $842,000
Q4 2022 Nov 07, 2023	BUY	$162.42 - $220.56 $812 - $1,102	5 Added 83.33%	11 $1.86 Million
Q3 2022 Nov 07, 2023	BUY	$160.42 - $256.21 $160 - $256	1 Added 20.0%	6 $1.12 Million
Q2 2022 Nov 07, 2023	SELL	$140.68 - $188.02 $422 - $564	-3 Reduced 37.5%	5 $812,000
Q1 2022 Nov 07, 2023	BUY	$161.19 - $257.96 $322 - $515	2 Added 33.33%	8 $1.51 Million
Q4 2021 Nov 07, 2023	BUY	$247.59 - $304.47 $1,485 - $1,826	6 New	6 $1.59 Million
Q1 2016 Nov 06, 2023	BUY	N/A	670	670 $18 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.